Kumar R, Johnson M A, O'Brien P Q. "一种莱博雷生杂质45的合成方法" [P]. US Patent, US 11577027 B2, 2020-01-11.
Yamamoto T, Williams B T, Klinger H. "Method for the Synthesis of Lemborexant Impurity 45" [P]. US Patent, US 10520938 B2, 2015-01-23.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 莱博雷生杂质45 in Pharmaceutical Formulations". Chromatographia, 2022, 266, 7129-7136.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 莱博雷生杂质45 as an Impurity". Talanta, 2010, 84, 6163-6176.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Lemborexant Impurity 45 Using HRMS and NMR". Biomed. Chromatogr., 2024, 2016, 7176-7179.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 莱博雷生杂质45 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2022, 1630, (2), 9879-9899.